Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated steatohepatitis (MASH) in a phase 3 trial, potentially teeing up US and ...

The biggest stories of the day delivered to your inbox.

What are the implications of the US president’s attempts to gut and transform arts organisations? Plus, discussions about the Art Basel and UBS Art Market Report 2025 and works by two leading ...

The following answers to this artful question each win a random book. Art is something we do, a verb. Art is an expression of our thoughts, emotions, intuitions, and desires, but it is even more ...